A Data Processing Workflow for Comprehensive Middle-down Analysis
A Fully Automated Data Workflow for Quality Monitoring of Oligonucleotide Therapeutics
Leveraging In-House NGS Validation for Virus Safety Assessment
PDA Letter September 5, 2024
MS-Based Profiling, Fingerprinting, & Speciation of Polymeric Excipients
Realize the Promise of Multi-Omics for Precision Medicine
Marie-Ange Kouassi September 1, 2024
Automated & Interactional Ion Channel Data Analysis
A Lean and Smart Approach for Setting Up an Antibody Development Platform
Validation Framework for NGS Assays in Viral Safety Testing
Genedata Selector
Optimizing CGT Product Development & Manufacturing
Off-the-Shelf Analysis Solution for GMP-Compliant NGS Assays
A Robust CETSA Data Analysis Automation Workflow For Routine Screening
SLAS Discovery July 3, 2024
High-Throughput Kinetics in Drug Discovery
Robust NGS Pipelines for Virus Detection
MS-based Analytics for the Investigation of In Vivo Biotransformation of Biotherapeutics
Automating R&D of Viral and Non-Viral Vectors for Cell and Gene Therapies
NGS-Based Biosafety Assessment of Biologics in GMP
Genedata Selector 10 Highlights
AI Automates SPR/BLI Binding Profile Assignment
A Single, Integrated Software Platform for LC/MS-based MAM Approaches
Product Characterization and Biosafety in GxP with NGS
Valentina Armiento May 30, 2024
Streamlining Computerized System Validation
Overcoming the Challenges of Disulfide Bond Characterization
Connecting the Dots for NGS in GMP Environments
Japan: What Digital Platforms Can Bring to Biomarker Researchers
Genedata Profiler 16.5 Highlights Video
AbbVie Streamlines Multi-Specifics Biologics Discovery and Engineering
In-House NGS-Based CQAs Assessment of Gene Therapies
Bispecific Antibodies: HT Generation, Design, Production, Evaluation
Gene Therapy Product Development & Manufacturing
Automating MS Analysis of Oligonucleotide Biotransformations
Validating NGS Assays in Light of Regulatory Changes
Urszula Cendrowska April 22, 2024
Ajinomoto Speeds up Cell Culture Media Development Projects with Genedata Bioprocess
Fully Automated NGS Assays in a GMP Environment
Considerations for a GMP-Compliant NGS Method
Nanopore Sequencing for AAV Vectors & DNA Impurities
Selector Playbooks: Automation of NGS Workflows
NGS Implementation for Adventitious Virus Detection
Accelerating Cell Therapy Product Development
Advancing Cell Therapies Using NGS as a Multi-Attribute Method
Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations
Cancer Discovery March 14, 2024
